通过神经母细胞瘤患者的F-FDG-PET/CT参数进行预后预测:系统性审查和元分析
Ruimin Hu1, Yan Zhang1, Siying Liu1
1Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in oncology
|July 31, 2023
概括
在18F-FDG PET/CT上较高的最大标准化吸收值 (SUVmax) 表明神经母细胞瘤患者的整体存活率 (OS) 较差. 代谢性瘤体积 (MTV) 和总损伤糖解 (TLG) 需要进一步验证作为预后预测因素.
科学领域:
- 在瘤学瘤学.
- 核医学就是核医学.
- 放射学 放射学是一门学科.
背景情况:
- 神经母细胞瘤是一种高风险的儿科癌症,预后可变.
- 18F-氧葡萄糖 (18F-FDG) 定子发射断层扫描-计算机断层扫描 (PET/CT) 评估瘤的新陈代谢.
- 神经母细胞瘤中PET/CT参数的预后价值尚未得到充分确立.
结论:
- 在18F-FDG PET/CT上SUVmax升高是神经母细胞瘤总生存率低的重要预测因素.
- 代谢性瘤体积和总损伤糖解可以作为潜在的预后指标,但需要在更大,更精心设计的研究中进一步调查.
关键词:
18F-FDG-PET/CT/CT-PET/CT/CT-PET/CT/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/CT-PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET/PET这就是MTVMTV的MTV.这是一辆SUVmax,SUVmax.这是TLG的TLG.这是一个元分析.神经母细胞瘤的神经母细胞瘤预后 预测 预测 预测更多相关视频
08:55A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
17.7K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K